论文部分内容阅读
目的探讨分析使用胺碘酮治疗快速性心律失常的临床效果与应用价值。方法将我院从2017年1月至2017年5月收治的308例快速性心律失常患者选取为此次研究对象,将其随机分成对照组与观察组,对照组患者使用常规治疗方法,观察组患者在此基础上加用胺碘酮进行治疗,对比两组患者的治疗效果。结果观察组患者的心率改善以及血压水平均比对照组患者更好,不良反应的发生率更低,组间数据比较,差异均具有统计学意义(P<0.05)。结论对于快速性心律失常的患者,在常规治疗基础上加以胺碘酮治疗,能够快速改善心律失常的情况,同时降低不良反应的发生,值得在临床中推广应用。
Objective To investigate the clinical effect and application value of amiodarone in the treatment of tachyarrhythmia. Methods A total of 308 patients with tachyarrhythmia admitted from January 2017 to May 2017 in our hospital were selected as the study subjects and randomly divided into control group and observation group. Patients in the control group were treated with conventional therapy and observation group Patients on this basis with amiodarone treatment, compared the two groups of patients with treatment. Results The improvement of heart rate and blood pressure in the observation group were better than those in the control group, and the incidence of adverse reactions was lower. There were significant differences in the data between groups (P <0.05). Conclusions In patients with tachyarrhythmia, amiodarone treatment based on routine treatment can rapidly improve the arrhythmia and reduce the incidence of adverse reactions, which is worth popularizing in clinic.